Is differentiated vulval intraepithelial neoplasia the precursor lesion of human papillomavirus-negative vulval squamous cell carcinoma?

International Journal of Gynecological Cancer

Volumn 21, Issue 7, 2011, Pages 1297-1305

  Kokka, Fani ^a   Singh, Naveena ^a   Faruqi, Asma ^a   Gibbon, Karen ^a   Rosenthal, Adam N ^a,b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer; Carcinogenesis; Differentiated; Etiology; Hyperplasia; Squamous; Vulva; Vulval intraepithelial neoplasia

Indexed keywords

CIDOFOVIR; IMIQUIMOD; KI 67 ANTIGEN; PROTEIN P16; PROTEIN P53; T6 ANTIGEN;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; DIFFERENTIATED VULVA INTRAEPITHELIAL NEOPLASIA; DISEASE ASSOCIATION; HISTOLOGY; HUMAN; PHOTODYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED VULVA INTRAEPITHELIAL NEOPLASIA; VULVA CARCINOMA; VULVA SQUAMOUS CELL CARCINOMA; VULVA TUMOR; VULVECTOMY; CARCINOMA IN SITU; FEMALE; PATHOLOGY; TUMOR RECURRENCE; VULVA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; VULVA; VULVAR NEOPLASMS;

EID: 84856076184     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822dbe26     Document Type: Review

References (72)

1. Judson PL, Habermann EB, Baxter NN, et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018-1022.
2. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-842. (Pubitemid 32586611)
3. Sturgeon SR, Brinton LA, Devesa SS, et al. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol. 1992;166:1482-1485.
4. Phillips N, Bachmann G. Vulvodynia: an often-overlooked cause of dyspareunia in the menopausal population. Menopausal Med. 2010;18:S1-S5.
5. O'Connell TX, Nathan LS, Satmary WA, et al. Non-neoplastic epithelial disorders of the vulva. Am Fam Physician. 2008;77:321-326.
6. Rouzier R, Morice P, Haie-Meder C, et al. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas. Gynecol Oncol. 2001;81:414-419. (Pubitemid 32494656)
7. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol. 1990;97:1135-1139.
8. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol. 2006;30:310-318. (Pubitemid 43740162)
9. van de Nieuwenhof HP, Massuger LF, van der Avoort IA, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45:851-856.
10. Eva LJ, Ganesan R, Chan KK, et al. Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases. J Reprod Med. 2008;53:397-401. (Pubitemid 351976409)
11. Ridley CM, Frankman O, Jones IS, et al. New nomenclature for vulvar disease: International Society for the Study of Vulvar Disease. Hum Pathol. 1989;20:495-496.
12. Scurry J, Hung J, Flowers L, et al. Ploidy in human papillomavirus positive and negative vulvar squamous cell carcinomas and adjacent skin lesions. Int J Gynecol Cancer. 1999;9:187-193. (Pubitemid 29302852)
13. Crum CP, McLachlin CM, Tate JE, et al. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol. 1997;9:63-69. (Pubitemid 27137230)
14. Crum CP. Carcinoma of the vulva: epidemiology and pathogenesis. Obstet Gynecol. 1992;79:448-454.
15. Kenter GG, Welters MJ, Valentijn AR, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med. 2009;361:1838-1847.
16. Rosenthal AN, Hopster D, Ryan A, et al. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. Br J Cancer. 2003;88:251-256. (Pubitemid 36255844)
17. Madsen BS, Jensen HL, van den Brule AJ, et al. Risk factors for invasive squamous cell carcinoma of the vulva and vagina - population-based case-control study in Denmark. Int J Cancer. 2008;122:2827-2834. (Pubitemid 351631386)
18. Goffin F, Mayrand MH, Gauthier P, et al. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J Med Virol. 2006;78:814-819.
19. Moore TO, Moore AY, Carrasco D, et al. Human papillomavirus, smoking, and cancer. J Cutan Med Surg. 2001;5:323-328. (Pubitemid 32843789)
20. van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol. 2005;97:645-651.
21. McNally OM, Mulvany NJ, Pagano R, et al. VIN 3: a clinicopathologic review. Int J Gynecol Cancer. 2002;12:490-495.
22. van Seters M, van Beurden M, de Craen AJ. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med. 2008;358:1465-1473.
23. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol. 2005;106:1319-1326. (Pubitemid 41668952)
24. Iversen T, Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol. 1998;91:969-972. (Pubitemid 28246933)
25. Rosenthal AN, Ryan A, Hopster D, et al. Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. Int J Cancer. 2002;99:549-554. (Pubitemid 34461607)
26. Rosenthal AN, Ryan A, Hopster D, et al. High frequency of loss of heterozygosity in vulval intraepithelial neoplasia (VIN) is associated with invasive vulval squamous cell carcinoma (VSCC). Int J Cancer. 2001;94:896-900.
27. Lin MC, Mutter GL, Trivijisilp P, et al. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia. Am J Pathol. 1998;152:1313-1318. (Pubitemid 28221883)
28. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med. 2005;50:807-810. (Pubitemid 41720964)
29. van de Nieuwenhof HP, van Kempen LC, de Hullu JA, et al. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. Cancer Epidemiol Biomarkers Prev. 2009;18:2061-2067.
30. Fox H, Wells M. Recent advances in the pathology of the vulva. Histopathology. 2003;42:209-216. (Pubitemid 36356852)
31. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis. 2006;10:161-169. (Pubitemid 44618506)
32. Scurry J, Campion M, Scurry B, et al. Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia. Int J Gynecol Pathol. 2006;25:176-181. (Pubitemid 44620182)
33. Wilkinson EJ, Teixeira MR. Pathology and genetics of tumours of the breast and female genital organs. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2003;230:316-320.
34. Medeiros F, Nascimento AF, Crum CP. Early vulvar squamous neoplasia: advances in classification, diagnosis, and differential diagnosis. Adv Anat Pathol. 2005;12:20-26. (Pubitemid 40614486)
35. Garland SM, Insinga RP, Sings HL, et al. Human papillomavirus infections and vulvar disease development. Cancer Epidemiol Biomarkers Prev. 2009;18:1777-1784.
36. Srodon M, Stoler MH, Baber GB, et al. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol. 2006;30:1513-1518. (Pubitemid 44808787)
37. Abell MR. Intraepithelial carcinomas of epidermis and squamous mucosa of vulva and perineum. Surg Clin North Am. 1965;45:1179-1198.
38. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol. 2001;20:16-30. (Pubitemid 32041755)
39. van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 2008;68:131-156.
40. McCluggage WG. Recent developments in vulvovaginal pathology. Histopathology. 2009;54:156-173.
41. van de Nieuwenhof HP, Bulten J, Hollema H, et al. Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma. Mod Pathol. 2011;24:297-305.
42. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol. 2008;27:125-135. (Pubitemid 351627985)
43. Preti M, van Seters M, Sideri M, et al. Squamous vulvar intraepithelial neoplasia. Clin Obstet Gynecol. 2005;48:845-861. (Pubitemid 43017723)
44. Jones RW. The natural history of vulvar intraepithelial neoplasia. Br J Obstet Gynaecol. 1995;102:764-766.
45. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPVand p53 expression. Am J Surg Pathol. 2000;24:429-441. (Pubitemid 30127480)
46. Hoevenaars BM, van der Avoort IA, deWilde PC, et al. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer. 2008;123:2767-2773.
47. Berek JS, Hacker NF, eds. Practical Gynecologic Oncology. 4th ed. Philadelpha, PA: Lippincott Williams &Wilkins; 2005.
48. Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study. Gynecol Oncol. 2007;107:219-222. (Pubitemid 47575715)
49. Le T, Menard C, Hicks-Boucher W, et al. Final results of a phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia. Gynecol Oncol. 2007;106:579-584. (Pubitemid 47302478)
50. Tristram A, Fiander A. Clinical responses to cidofovir applied topically to women with high grade vulval intraepithelial neoplasia. Gynecol Oncol. 2005;99:652-655. (Pubitemid 41693335)
51. Soergel P, Hillemanns P. Photodynamic therapy for intraepithelial neoplasia of the lower genital tract. Photodiagnosis Photodyn Ther. 2010;7:10-14.
52. Küppers V, Stiller M, Somville T, et al. Risk factors for recurrent VIN. Role of multifocality and grade of disease. J Reprod Med. 1997;42:140-144. (Pubitemid 27164434)
53. Hillemanns P, Wang X, Staehle S, et al. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol. 2006;100:271-275. (Pubitemid 43075260)
54. Sykes P, Smith N, McCormick P, et al. High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999. Aust N Z J Obstet Gynaecol. 2002;42:69-74. (Pubitemid 34173094)
55. Andreasson B, Bock JE. Intraepithelial neoplasia in the vulvar region. Gynecol Oncol. 1985;21:300-305. (Pubitemid 15059966)
56. Rettenmaier MA, Berman ML, DiSaia PJ. Skinning vulvectomy for the treatment of multifocal vulvar intraepithelial neoplasia. Obstet Gynecol. 1987;69:247-250. (Pubitemid 17015542)
57. Andreasson B, Moth I, Jensen SB, et al. Sexual function and somatopsychic reactions in vulvectomy-operated women and their partners. Acta Obstet Gynecol Scand. 1986;65:7-10. (Pubitemid 16105513)
58. Thuesen B, Andreasson B, Bock JE. Sexual function and somatopsychic reactions after local excision of vulvar intra-epithelial neoplasia. Acta Obstet Gynecol Scand. 1992;71:126-128.
59. Campion MJ, Hacker NF. Vulvar intraepithelial neoplasia and carcinoma. Semin Cutan Med Surg. 1998;17:205-212. (Pubitemid 28435982)
60. Ordi J, Alejo M, Fusté V, et al. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Am J Surg Pathol. 2009;33:1659-1665.
61. Tate JE, Mutter GL, Boynton KA, et al. Monoclonal origin of vulvar intraepithelial neoplasia and some vulvar hyperplasias. Am J Pathol. 1997;150:315-322. (Pubitemid 27027120)
62. van Seters M, ten Kate FJ, van Beurden M, et al. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. J Clin Pathol. 2007;60:504-509.
63. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol. 1995;147:545-560.
64. Pinto AP, Miron A, Yassin Y, et al. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma. Mod Pathol. 2010;23:404-412.
65. Roma AA, Hart WR. Progression of simplex (differentiated) vulvar intraepithelial neoplasia to invasive squamous cell carcinoma: a prospective case study confirming its precursor role in the pathogenesis of vulvar cancer. Int J Gynecol Pathol. 2007;26:248-253. (Pubitemid 46986057)
66. Aulmann S, Schleibaum J, Penzel R, et al. Gains of chromosome region 3q26 in intraepithelial neoplasia and invasive squamous cell carcinoma of the vulva are frequent and independent of HPV status. J Clin Pathol. 2008;61:1034-1037.
67. Rolfe KJ, Eva LJ, MacLean AB, et al. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer. 2001;11:113-118. (Pubitemid 32381659)
68. van der Avoort IA, van der Laak JA, Paffen A, et al. MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Mod Pathol. 2007;20:770-778. (Pubitemid 46933448)
69. Ruhul Quddus M, Xu C, Steinhoff MM, et al. Simplex (differentiated) type VIN: absence of p16INK4 supports its weak association with HPV and its probable precursor role in non-HPV related vulvar squamous cancers. Histopathology. 2005;46:718-720. (Pubitemid 40834838)
70. Santos M, Montagut C, Mellado B, et al. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol. 2004;23:206-214. (Pubitemid 38857109)
71. Ueda Y, Enomoto T, Miyatake T, et al. Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa. Am J Clin Pathol. 2004;122:266-274. (Pubitemid 38971360)
72. Pinto AP, Lin MC, Sheets EE, et al. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva. Gynecol Oncol. 2000;77:171-176. (Pubitemid 30217321)